Optimal timing for collection of PBPC after glycosylated G-CSF administration

Bone Marrow Transplant. 1998 Feb;21(4):365-8. doi: 10.1038/sj.bmt.1701099.

Abstract

Daily administration of granulocyte colony-stimulating Factor (G-CSF) results in progenitor cell mobilization with maximum blood levels achieved after 4-7 days. In this study the short-term effects of glycosylated G-CSF at a dose of 5 microg/kg s.c. were determined so as to allow optimization of the timing of progenitor cell collection. In the first study involving 20 normal volunteers, a significant fall in neutrophil count and G-CSF levels was observed 2 h after the G-CSF injection. To investigate this phenomenon serial measurements were made in a further six volunteers after the 6th daily injection of G-CSF. A fall in the neutrophil count occurred which was maximal at 1 h and recovered to baseline within 3 h. There was also a fall in CD34+ cells (P = 0.034), GM-CFC (P = 0.025) and BFU-E (P = 0.066) and recovery to baseline levels took 4-12 h. We conclude that glycosylated G-CSF should not be given immediately prior to stem cell collection.

MeSH terms

  • Adult
  • Antigens, CD34 / metabolism
  • Blood Component Removal / methods*
  • Colony-Forming Units Assay
  • Glycosylation
  • Granulocyte Colony-Stimulating Factor / administration & dosage*
  • Granulocyte Colony-Stimulating Factor / blood
  • Granulocyte Colony-Stimulating Factor / chemistry
  • Hematopoietic Stem Cell Transplantation*
  • Hematopoietic Stem Cells / cytology
  • Hematopoietic Stem Cells / drug effects
  • Hematopoietic Stem Cells / immunology
  • Humans
  • Leukocyte Count
  • Male
  • Neutrophils / cytology
  • Neutrophils / drug effects
  • Neutrophils / immunology
  • Time Factors

Substances

  • Antigens, CD34
  • Granulocyte Colony-Stimulating Factor